<DOC>
	<DOCNO>NCT01641159</DOCNO>
	<brief_summary>The purpose study evaluate whether buspirone effective prevent relapse cocaine-dependent adult inpatient/residential treatment planning enter outpatient treatment upon inpatient/residential discharge .</brief_summary>
	<brief_title>Study Buspirone Relapse-Prevention Adults With Cocaine Dependence</brief_title>
	<detailed_description>The primary objective evaluate efficacy buspirone , relative placebo , prevent relapse cocaine-dependent adult inpatient/residential treatment planning enter outpatient treatment upon inpatient/residential discharge . Secondary objective include evaluate impact buspirone , relative placebo , drug-abuse outcome factor may mediate buspirone 's efficacy relapse-prevention treatment .</detailed_description>
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Cocaine-Related Disorders</mesh_term>
	<mesh_term>Buspirone</mesh_term>
	<mesh_term>Cocaine</mesh_term>
	<criteria>1. 18 year age old 2. able understand study , understood , provide write informed consent English 3. meet DSMIVTR diagnostic criterion current ( within last 12 month ) dependence cocaine , must selfreport use crack cocaine minimum four time 28 day prior inpatient/residential admission , must report typical pattern use least week 4. willingness comply study procedure medication instruction 5. enrolled inpatient/residential program participate CTP , schedule inpatient/residential treatment 1219 day randomize , plan enroll local outpatient treatment end active treatment phase ( i.e. , study week 15 ) 6. female child bear potential , agree use one follow method birth control : oral contraceptive contraceptive patch barrier ( diaphragm condom ) intrauterine contraceptive system levonorgestrel implant medroxyprogesterone acetate contraceptive injection complete abstinence sexual intercourse hormonal vaginal contraceptive ring 1. meet DSMIVTR diagnostic criterion current ( within last 12 month ) opioid dependence 2. medical psychiatric condition , judgment study physician , would make study participation unsafe would make treatment compliance difficult . Medical condition may compromise participant safety study conduct include , limited : AIDS accord current CDC criterion AIDS liver function test great 3X upper limit normal serum creatinine great 2 mg/dL 3. psychiatric disorder require continue treatment psychotropic medication 4. know suspected hypersensitivity buspirone 5. pregnant breastfeed 6. use follow medication within 14 day randomization : monoamine oxidase ( MAO ) inhibitor phenelzine ( Nardil ) , selegiline ( Eldepryl ) , isocarboxazid ( Marplan ) , tranylcypromine ( Parnate ) 7. take medication , judgment study physician , may produce interaction buspirone sufficiently dangerous exclude patient participate study . Alternatively , study physician , consultation patient physician , may elect withdraw patient problem medication randomization . Some possible interaction discuss section 8.8 . 8. anyone , judgment investigator , would expect complete study protocol ( e.g. , due relocation clinic area , probable incarceration , etc . ) 9. significant suicidal/homicidal risk</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Cocaine</keyword>
	<keyword>Crack</keyword>
	<keyword>Buspirone</keyword>
	<keyword>Relapse Prevention</keyword>
</DOC>